Diagnostic microarrays in hematologic oncology: Applications of high- and low-density arrays

Molecular Diagnosis and Therapy

Volumn 13, Issue 2, 2009, Pages 91-102

  Nasedkina, Tatyana V ^a   Guseva, Natalia A ^a   Gra, Olga A ^a,b   Mityaeva, Olga N ^a   Chudinov, Alexander V ^a   Zasedatelev, Alexander S ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BIOCHIP; BIOTRANSFORMATION; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOTYPE; HEMATOLOGIC MALIGNANCY; HUMAN; MICROARRAY ANALYSIS; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL LYMPHOMA; T LYMPHOCYTE RECEPTOR GENE;

CHROMOSOME ABERRATIONS; GENE REARRANGEMENT; GENES, T-CELL RECEPTOR GAMMA; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 67650501038     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/bf03256318     Document Type: Review

References (102)

1. Perez-Diez A, Morgun A, Shulzhenko N. Microarrays for cancer diagnosis and classification. Adv Exp Med Biol 2007; 593: 74-85
2. Wiltgen M,Tilz GP. DNA microarrayanalysis: principles and clinical impact. Hematology 2007; 12 (4): 271-87
3. Microarray station: DNA and protein chips [online]. Available from URL: http://www.microarraystation.com [Accessed 2009 Mar 18]
4. Springer protocols [online]. Available from URL: http://www. springerprotocols. com [Accessed 2009 Mar 18]
5. Lee NH, Saeed AI. Microarrays: an overview. Methods Mol Biol 2007; 353: 265-300
6. Petersen DW, Kawasaki ES. Manufacturing of microarrays. Adv Exp Med Biol 2007; 593: 1-11
7. Page GP, Zakharkin SO, Kim K, et al. Microarray analysis. Methods Mol Biol 2007; 404: 409-30
8. Hardiman G. Microarrays technologies 2006: an overview. Pharmacogenomics 2006; 7 (8): 1153-8
9. Trevino V, Falciani F, Barrera-Saldaña HA. DNA microarrays: a powerful genomic tool for biomedical and clinical research. Mol Med 2007 Sep-Oct; 13 (9-10): 527-41
10. Pollack JR. A perspective on DNA microarrays in pathology research and practice. Am J Pathol 2007; 171 (2): 375-85
11. Jordan BR. DNA microarrays in the clinic: how soon, how extensively? Bioessays 2007; 29 (7): 699-705
12. Heller T, Kirchheiner J, Armstrong VW, et al. AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping. Ther Drug Monit 2006; 28 (5): 673-7
13. Mook S, Van't Veer LJ, Rutgers EJ, et al. Cancer Genomics Proteomics 2007; 4 (3): 147-55
14. Marchionni L, Wilson RF, Wolff AC, et al. Systematic review: gene expression profiling assays in early-stage breast cancer. Ann Intern Med 2008; 148 (5): 358-69
15. Van Berkum NL, Holstege FC. DNA microarrays: raising the profile. Curr Opin Biotechnol 2001; 12: 48-52
16. Hughes TR, Shoemaker DD. DNA microarrays for expression profiling. Curr Opin Chem Biol 2001; 5: 21-5
17. Alizadeh A, Eisen M, Davis RE, et al. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol 1999; 64: 71-8
18. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11
19. Sears C, Armstrong SA. Microarrays toidentify new therapeutic strategies for cancer. Adv Cancer Res 2007; 96: 51-74
20. Ek S, Borrebaeck CAK. Parallel gene expression profiling of mantle cell lymphoma. Curr Genomics 2007; 8 (3): 171-9
21. Harjunpaa A, Taskinen M, Nykter M, et al. Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP. Br J Haematol 2006; 135: 33-42
22. Islam TC, Asplund AC, Lindvall JM, et al. High level ofcannabinoid receptor 1, absence of regulator of G protein signaling 13 and differential expression of cyclin D1 in mantle cell lymphoma. Leukemia 2003; 17: 1880-90
23. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003; 3: 185-97
24. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-7
25. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lym-phocytic leukemia. J Exp Med 2001; 194: 1639-47
26. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41-7
27. Ross ME, Zhou X, Song G, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003; 102: 2951-9
28. Andersson A, Ritz C, Lindgren D, et al. Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well of minimal residual disease status. Leukemia 2007; 21 (6): 1198-203
29. Willman CL. Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML? Best Pract Res Clin Haematol 2008 Mar; 21 (1): 21-8
30. Metzeler KH, Hummel M, Bloomfield CD, et al. An 86 probe set gene expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood 2008; 112 10: 4193-201
31. Kohlmann A, Haschke-Becher E, Wimmer B, et al. Intraplatform reproducibility and technical precision of gene expression profiling in 4 laboratories investigating 160 leukemia samples: the DACH study. Clin Chem 2008; 54 (10): 1705-15
32. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-21
33. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998; 20: 207-11
34. Suela J, Alvarez S, Cigudosa JC. DNA profiling by arrayCGH in acute myeloid leukemia and myelodisplastic syndromes. Cytogenet Genome Res 2007; 118 (2-4): 304-9
35. Mrózek K. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype. Semin Oncol 2008; 35 (4): 365-77
36. Hosoya N, Sanada M, Nannya Y, et al. Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high resolution array-based comparative genomic hybridization. Genes Chromosomes Cancer 2006; 45 (5): 482-94
37. Chen W, Houldsworth J, Olshen AB, et al. Array comparative genomic hybridization reveals genomic copy number changes associated with out-comein diffuse large B-cell lymphomas. Blood 2006 Mar 15; 107 (6): 2477-85
38. Kennedy GC, Matsuzaki H, Dong S, et al. Large-scale genotyping of complex DNA. Nat Biotechnol 2003; 21: 1233-7
39. Butler H, Ragoussis J. BeadArray-based genotyping. Methods Mol Biol 2008; 439: 53-74
40. White SJ, Vissers LE, Geurts van Kessel A, et al. Variation of CNV distribution in five different ethnic populations. Cytogenet Genome Res 2007; 118 (1): 19-30
41. Lindblad-Toh K, Tanenbaum DM, Daly MJ, et al. Loss-of-heterozygosity analysis of small-cell lung carcinomas using singlenucleotide polymorphism arrays. Nat Biotechnol 2000; 18: 1001-5
42. Primdahl H, Wikman FP, von der Maase H, et al. Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays. J Natl Cancer Inst 2002; 94: 216-23
43. Raghavan M, Lillington DM, Skoulakis S, et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 2005; 65: 375-8
44. Fitzgibbon J, Smith LL, Raghavan M, et al. Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias. Cancer Res 2005; 65: 9152-4
45. Bungaro S, Raghavan M, Dell'Oro MG, et al. Assessment of submicroscopic genetic lesions by single nucleotide polymorphism arrays in a child with acute myeloid leukemia and FLT3-internal tandem duplication. Haematologica 2006; 91: 998-1000
46. Kawamata N, Ogawa S, Zimmermann M, et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 2008; 111 (2): 776-84
47. Gorletta TA, Gasparini P, D'Elios MM, et al. Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype. Genes Chromosomes Cancer 2005; 44: 334-7
48. Nielaender I, Martin-Subero JI, Wagner F, etal. Partial uniparental disomy: a recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma. Leukemia 2006; 20: 904-5
49. Mikhailovich V, Gryadunov D, Kolchinsky A, et al. DNA microarrays in the clinic: infectious diseases. Bioessays 2008; 30 (7): 673-82
50. Rubina AY, Kolchinsky A, Makarov AA, et al. Why 3-D? Gel-based microarrays in proteomics. Proteomics 2008; 8 (4): 817-31
51. Mikhailovich V, Lapa S, Gryadunov D, et al. Identification of rifampinresistant mycobacterium tuberculosis strains by hybridization, PCR and ligase detection reaction on oligonucleotide microchips. J Clin Microbiol 2001; 39: 2531-40
52. Rubina AY, Pan'kov SV, Dementieva EI, et al. Hydrogel drop microchips with immobilized DNA: properties and methods for large-scale production. Anal Biochem 2004; 325 (1): 92-106
53. Rubina AY, Dementieva EI, Stomakhin AA, et al. Hydrogel-based protein microchips: manufacturing, properties, and applications. Biotechniques 2003; 34 (5): 1008-114, 1016-20, 1022
54. Bavykin SG, Akowski JP, Zakhariev VM, et al. Portable system for microbial sample preparation and oligonucleotide microarray analysis. Appl Environ Microbiol 2001; 67 (2): 922-8
55. Rabbits TH. Chromosomal translocations in human cancer. Nature 1994; 372: 143-9
56. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997; 278: 1059-64
57. Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukaemia: current status and future perspectives. Lancet Oncol 2001; 2: 597-607
58. Shrappe M. Evolution of BFM trials for childhood ALL. Ann Hematol 2004; 83 Suppl. 1: 121-3
59. Möricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008; 111 (9): 4477-89
60. Rubnitz JE, Wichlan D, Devidas M, et al. Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. J Clin Oncol 2008; 26 (13): 2186-91
61. Karachunskiy A, Herold R, von Stackelberg A, et al. Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia. Leukemia 2008; 22 (6): 1144-53
62. Braziel RM, Shipp MA, Feldman AL, et al. Molecular diagnostics. Hematology 2003; 279-93
63. Haferlach T, Kern W, Schnittger S, et al. Modern diagnostics in acute leukemias. Crit Rev Oncol Hematol 2005; 56 (2): 223-34
64. Pallisgaard N, Hokland P, Riishoj DC, et al. Multiplex reverse transcriptionpolymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 1998; 92: 574-88
65. Scurto P, Rocha MH, Kane JR, et al. A multiplex RT-PCR assay for the detection of chimeric transcripts encoded by the risk-stratifying trans-locations of pediatric acute lymphoblastic leukemia. Leukemia 1998; 12: 1994-2005
66. Nasedkina TV, Zharinov VS, Isaeva EA, et al. Clinical screening of gene rearrangements in childhood leukemia by using a multiplex poly-merase chain reaction-microarray approach. Clin Cancer Res 2003; 9 (15): 5620-9
67. Mitiaeva ON, Nasedkina TV, Zharinov VS, et al. Analysis of chromosome translocations involving MLL by hybridization with an oligonucleotide microarray [in Russian]. Mol Biol 2004; 38 (3): 449-56
68. Maroc N, Morel A, Beillard E, et al. A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia. Leukemia 2004; 18 (9): 1522-30
69. Pihan G. Detection of gene fusions in acute leukemia using bead microarrays. Curr Protoc Cytom 2006 Feb; Chapter 13: Unit 13.7
70. Chun SM, Kim YL, Choi HB, et al. Identification of leukemia specific fusion gene transcripts with a novel oligonucleotide array. Mol Diagn Ther 2007; 11 (1): 21-8
71. Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007; 370: 240-50
72. Eguchi M, Eguchi-Ishimae M, Greaves M. Molecular pathogenesis of MLL-associated leukemias. Int J Hematol 2005; 82 (1): 9-20
73. Guseva NA, Nurutdinova OS, Chudinov AV, et al. Leukemia biochip analysis of chromosomal translocations in childhood leukemia in Russia using hybridization and on-chip-PCR approaches [abstract]. Eur J Hum Genet 2008; 16 Suppl. 2: 30
74. Khodakov DA, Zakharova NV, Gryadunov DA, et al. An oligonucleotide microarray for multiplex real-time PCR identification of HIV-1, HBV, and HCV. Biotechniques 2008; 44 (2): 241-6
75. Spagnolo DV, Ellis DW, Juneja S, et al. The role of molecular studies in lymphoma diagnosis: a review. Pathology 2004; 36: 19-44
76. Dictor M, Warenholt J, Isinger A. Resolving T-cell receptor clonality in two and genotype in four multiplex polymerase chain reactions. Haematologica 2005; 90: 1524-32
77. Gra OA, Sidorova JV, Nikitin EA, et al. Analysis of TCR gamma gene rearrangements using oligonucleotide microchip: a novel approach for the determination of T-cell clonality. J Mol Diagn 2007; 9 (2): 249-57
78. Malik UR, Oleksowicz L, Dutcher JP, et al. Atypical clonal T-cell proliferation in infectious mononucleosis. Med Oncol 1996; 13: 207-13
79. Maini MK, Casorati G, Dellabona P, et al. T-cell clonality in immune responses. Immunol Today 1999; 20: 262-6
80. Banér J, Marits P, Nilsson M, et al. Analysis of T-cell receptor V beta gene repertoires after immune stimulation and in malignancy by use of padlock probes and microarrays. Clin Chem 2005; 51 (4): 768-75
81. Nebert DW. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am J Hum Genet 1997; 60: 265-71
82. Nebert DW, McKinnon RA, Puga A. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 1996; 15: 273-80
83. Elion GB. The purine path to chemotherapy. Science 1989; 244: 441-7
84. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651-62
85. McLeod HL, Lin JS, Scott MC, et al. Thiopurine methyltransferase activity in American White subjects and Black subjects. Clin Pharmacol Ther 1994; 55: 15-20
86. Krynetski EY, Evans EE. Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm. Pharm Res 1999; 16 (3): 342-9
87. Schaeffeler E, Fischer C, Brockmeier D, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 2004; 14: 407-17
88. Otterness D, Szumlanski C, Lennard L, et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther 1997; 62: 60-73
89. McLeod HL, Pritchard SC, Githang'a J, et al. Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics 1999; 9: 773-6
90. Ameyaw MM, Collie-Duguid ES, Powrie RH, et al. Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet 1999; 8: 367-70
91. Collie-Duguid ES, Pritchard SC, Powrie RH, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 1999; 9: 37-42
92. Nasedkina TV, Fedorova OE, Glotov AS, et al. Rapid genotypingofcommon deficient thiopurine S-methyltransferase alleles using the DNA-microchip technique. Eur J Hum Genet 2006; 14 (9): 991-8
93. Samochatova EV, Chupova NV, Rudneva A, et al. TPMT genetic variations in populations of the Russian Federation. Pediatr Blood Cancer 2009 Feb; 52 (2): 203-8
94. Chupova NV, Samochatova EV, Roudneva AE, et al. The genetic polymorphism of TPMT in the therapy of children with acute lymphoblastic leukemia [in Russian]. Hematol Transfusiol 2005; 50 (6): 3-9
95. Balta G, Yuksek N, Ozyurek E, et al. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Am J Hematol 2003; 73 (3): 154-60
96. Krajinovic M, Richer C, Sinnett H, et al. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2000; 9 (6): 557-62
97. Krajinovic M, Labuda D, Mathonnet G, et al. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin Cancer Res 2002; 8 (3): 802-10
98. Rocha JC, Cheng C, Liu W, et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 2005; 105 (12): 4752-8
99. Bolufer P, Collado M, Barragan E, et al. Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia. Br J Haematol 2007 Feb; 136 (4): 590-6
100. Glotov AS, Nasedkina TV, Ivashchenko TE, et al. Biochip development for polymorphism analysis in biotransformation system genes [in Russian]. Mol Biol 2005; 39 (3): 403-12
101. Gra OA, Glotov AS, Nikitin EA, et al. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients. Am J Hematol 2008; 83 (4): 279-87
102. Gra OA, Glotov AS, Kozhekbaeva Zh, et al. Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia [in Russian]. Mol Biol (Mosk) 2008; 42 (2): 214-25